Vericel Corporation (VCEL) PT Raised to $20 at BTIG
Tweet
Share
E-mailGet Alerts VCEL Hot Sheet
Price: $46.14 -0.6%
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Join SI Premium – FREE
BTIG analyst Ryan Zimmerman raised the price target on Vericel Corporation (NASDAQ: VCEL) to $20.00 (from $17.00) while maintaining a Buy rating following strong results driven by both MACI and Epicel growth.
Zimmerman said the guidance raise was 'encouraging' as both biopsy growth and expanding surgeon usage are driving adoption beyond early adoption, in their view.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Day One Biopharmaceuticals (DAWN) PT Raised to $38 at Jones Trading on OJEMDA approval, sees $900M peak sales
- Craig-Hallum Assumes Guardant Health (GH) at Buy, 'We think that GH is undervalued'
- Jefferies Downgrades Enphase Energy (ENPH) to Hold, 'Still Muddling Through'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
BTIGSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
